Last reviewed · How we verify
tadalafil once a day [T(OaD)] — Competitive Intelligence Brief
phase 3
Small molecule
Live · refreshed every 30 min
Target snapshot
tadalafil once a day [T(OaD)] (tadalafil once a day [T(OaD)]) — Eli Lilly and Company.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| tadalafil once a day [T(OaD)] TARGET | tadalafil once a day [T(OaD)] | Eli Lilly and Company | phase 3 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- tadalafil once a day [T(OaD)] CI watch — RSS
- tadalafil once a day [T(OaD)] CI watch — Atom
- tadalafil once a day [T(OaD)] CI watch — JSON
- tadalafil once a day [T(OaD)] alone — RSS
Cite this brief
Drug Landscape (2026). tadalafil once a day [T(OaD)] — Competitive Intelligence Brief. https://druglandscape.com/ci/tadalafil-once-a-day-t-oad. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab